Physician profile
Chris Andersen
NPI 1255398467
$602.39
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $143 · 2021: $44.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $74.10 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $72.78 | 2019-2020 | |
| Davol INC. | $59.44 | 2019 | |
| Amniox Medical, INC. | $36.42 | 2019 | |
| Advanced Accelerator Applications | $36.27 | 2019 | |
| Boston Scientific Corporation | $34.58 | 2020 | |
| Acell, INC. | $31.95 | 2019 | |
| Abbott Laboratories | $31.25 | 2020 | |
| Integra Lifesciences Corporation | $27.48 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.40 | 2019-2020 | |
| Angiodynamics, INC. | $23.09 | 2019 | |
| Abbvie INC. | $18.18 | 2021 | |
| Ethicon US, LLC | $17.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.80 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.00 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.91 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.28 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $15.18 | 2020 | |
| Genentech USA, INC. | $11.29 | 2021 | |
| Seagen INC. | $10.85 | 2019 | |
| Olympus America INC. | $10.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.